Institutional Ownership Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA). We have compiled data on the 10 institutions that hold shares in the stock, with a total of 96,660 shares, which have been reported (via 13F filing form) to have a value of $171,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
43,524
shares
|
$77,037
0.0% of portfolio
|
Q2 2024
Reduced 1.36%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
24,267
shares
|
$42,952
0.0% of portfolio
|
Q1 2025
Added 104.73%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
15,326
shares
|
$27,127
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
9,001
shares
|
$15,931
0.0% of portfolio
|
Q1 2025
Added 156.44%
|
|
|
Gamma Investing LLC
Foster City, CA |
Jul 14, 2025 Q2 2025 |
3,456
shares
|
$6,117
0.0% of portfolio
|
Q2 2025
Added 54.77%
|
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
675
shares
|
$1,194
0.0% of portfolio
|
Q4 2024
Added 229.27%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
307
shares
|
$543
0.0% of portfolio
|
Q3 2024
Reduced 25.49%
|
|
|
Optiver Holding B.V.
Amsterdam, P7 |
May 15, 2025 Q1 2025 |
101
shares
|
$178
0.0% of portfolio
|
Q4 2024
Reduced 99.88%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2025 Q1 2025 |
3
shares
|
$5
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|